<!DOCTYPE html>

<html> 

<head> <!-- /main page header -->
  <meta charset="UTF-8">
   <meta name="format-detection" >
   <meta name="viewport" content="user-scalable=no, initial-scale=5, minimum-scale=1, maximum-scale=5">
   <title>BD-MIMS</title>
   <link rel="stylesheet" href="css/main.css">
   <link rel="stylesheet" href="css/themes/default/jquery.mobile-1.3.1.min.css">
   <script src="js/jquery.js"></script>
   <script src="js/jqm.js"></script>
   <script scr="js/cordova.js"type="text/javascript"></script>
   <script>
    function init() {
      document.addEventListener("deviceready", onDeviceReady, false);
    }

    function onDeviceReady() {
      alert('Damn Niagga, its playtime!');
    }
  </script>
   
</head> <!-- /main page header -->


<body onload="init()"> 


<!-- /................page............................ -->


<div data-role="page" id="" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>Non-Steroid drugs    </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

<ul data-role="listview" data-inset="true" data-theme="b">        
     
  <li><a href="#DICLOFENAC SODIUM">DICLOFENAC SODIUM</a></li>  
  <li><a href="#EMEDASTINE DIFUMARATE">EMEDASTINE DIFUMARATE</a></li> 
  <li><a href="#KETOROLAC">KETOROLAC</a></li>
  <li><a href="#KETOTIFEN">KETOTIFEN</a></li>

  <li><a href="#LODOXAMIDE">LODOXAMIDE</a></li>  
  <li><a href="#OLOPATADINE">OLOPATADINE</a></li> 
  <li><a href="#PEMIROLAST">PEMIROLAST</a></li>
  <li><a href="#SODIUM CROMOGLYCATE">SODIUM CROMOGLYCATE</a></li>
          
</ul>
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->

<div data-role="page" id="DICLOFENAC SODIUM" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> DICLOFENAC SODIUM   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3> DICLOFENAC SODIUM: Eye Drop. </h3>
          <p>  Diclofenac sodium, a nonsteroidal substance with anti-inflammatory & analgesic effects: eye drop.<BR><BR>
           <strong>Ind:</strong> Ch. non-infectious conjunctivitis, penetrating wound; inhibition of miosis during cataract surgery; post operative & pre-operative prevention of cystoid macular oedema associated with lens extraction & intraocular lens implantation.
Use: 1 drop 3-5 times daily.  </p>
        </div><!-- collapsible -->
        
        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ANFENAC Eye Drop Nipa</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 80.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ANODYNE Eye Drop Ibn Sina</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 75.00 IP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>CLOFENAC Eye Drop Square</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 75.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>DICLOFEN Eye Drop Opso Saline</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 40.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>DICLON Eye Drop Reman</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 75.86 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ERDON Eye Drop Aristovision</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 80.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>INTAFENAC Eye Drop Incepta</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 75.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>MOBIFEN Eye Drop ACI</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 75.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>NOPAIN Eye Drop Drug Inter</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 60.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>PROFENAC Eye Drop Popular</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 75.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>REUTREN Eye Drop Gaco</h3>
            <p>Diclofenac sodium 0.1%: eye drop. 5ml drop: 70.00 MRP</p>   
        </div><!-- collapsible -->

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->


<div data-role="page" id="EMEDASTINE DIFUMARATE" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> EMEDASTINE DIFUMARATE   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3> EMADINE Eye Drop Alcon/Globex </h3>
          <p> Emedastine difumarate 8.84mg/ml, equivalent to emedastine 0.5mg/ml (or 0.05%): Eye drop. <br><br>

          <strong>Mode of action:</strong> Emedastine is an anti-allergic and ophthalmic decongestant. It is a potent selective and topically effective histamine H1 receptor antagonist. In vivo topical ocular administration of emedastine produces a concentrationde-pendent inhibition of histamine-
stimulated conjunctival vascular permeability. Studies with emedastine have not shown effects on adrenergic, dopaminergic, & serotonin receptors. <BR><BR>

<strong>Ind:</strong> Symptomatic treatment of seasonal allergic conjunctivitis.<br><br>

<strong>C/I:</strong> Hypersensitivity to emedastine or any
component of the product.<br><br>

A/R: The most common adverse reaction reported is ocular discomfort (transient burning or stinging upon instillation). Other commonly reported ocular adverse reactions include- dry eye, ocular hyperemia, ocular pruritus, blurred vision, corneal staining, tearing, lid edema, foreign body sensation, conjunctivitis, keratitis, infiltrate, hordeolum, lid margin crusting, eye fatigue, ocular irritation, decreased visual acuity, sticky sensation, ocular dischagre, conjunctival edema, accidental injury, and photophobia.Occasional non-ocular adverse events were headache & rhinitis, cold syndrome, pain & back pain. <br><br>

Warnings & <strong>Precautions:</strong> Ocular corneal infiltrates were reported with the use of emedastine. In case of corneal infiltrates, the product should be discontinued and appropriate management should be implemented. Benzalkonium chloride used as preservative in this product has been reported to cause punctate kcratopathy and/or toxic ulcerative keratopathy. Contact lenses: patients should be instructed to wait 10-15 minutes after instillation of emedastine drop before inserting contact lenses. Emedastine should not be administered while wearing contact lenses.
Effects on ability to drive: As with other ocular medication, if transient blurred vision occurs at instillation, the patient should wait until the vision clears before driving or using mchinery.Elderly use: Emedastine has not been studied in elderly patients older than 65 years, and therefore its use is not recommended in this population. Pediatric use: Emedastine may be used in pediatric patients (3 years of age and older) with same dosage as in adults.Use in hepatic and renal impairment: Emedastine has not been studied in these patients and therefore, its use is not recommended in this population.<br><br>

Pregnancy & lactation: No reproductive toxicity was observed in a study in rabbits. Up to now, there are too few data to evaluate a potential malformative effect of emedastine when given during pregnancy. Thus, it is recommended not to use during pregnancy.Emedastine has been identified in the milk of rats following oral administration. It is not known whether topical administration to humans could result in sufficient systemic absorption to produce detectable quantities in breast milk. However, emedastine is not recommended for lactating mothers.<br><br>

<strong>Dosage & admin:</strong> 1 drop should be applied to the affected eye(s) twice daily. Emedastine has not been studied in clinical trials beyond 6 weeks.
Emedastine should not be used for longer than 4 weeks after first opening.
<br><br>

Drug inter: In case of concomitant therapy with other ophthalmic medicine, on interval of 10 minutes should be allowed between successive application. No specific interaction studies were
perfomed with emedastine.
Storage: Shelf-life 2 years. Not store above 25Â°C. 5ml drop: 287.00 MRP   </p>
        </div><!-- collapsible -->
        


      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->


<div data-role="page" id="KETOROLAC" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> KETOROLAC   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3> KETOROLAC TROMETHAMINE: Eye Drop  </h3>
          <p> Ketorolac tromethamine is a nonsteroidal anti- inflammatory drug, available for ophthalmic use as 0.5% (5mg/ml) sterile isotonic aqueous solution or eye drop.<br><br>

<strong>Mode of action:</strong> Its action is thought to be due, in part, to its ability to inhibit prostaglandin biosynthesis. Ocular administration of ketorolac tromethamine reduces prostaglandin E2 levels in aqueous humor. It has no significant effect upon intraocular pressure.<br><br>

<strong>Ind:</strong> Indicated for- i. the relief of ocular itching due to seasonal allergic conjunctivitis, ii. prophylaxis and reduction of inflammation and associated symptoms following ocular surgery. <br><br>

<strong>C/I:</strong> Patients wearing soft contact lenses and patients having hypersensitivity reaction to ketorolac tromethamine. Benzalkonium chloride and disodium edetate.<br><br>

<strong>S/E:</strong> Transient stinging and burning on instillation, ocular irritation, allergic reactions, superficial ocular infections and superficial keratitis. <br><br>


<strong>Precautions:</strong> It should be used with caution in patients with known bleeding tendencies or who are receiving other medications which may prolong bleeding time. There is the potential for cross-sensitivity to acetyls-alicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory agents. Therefore one should be careful when treating individuals who have previously exhibited sensitivities to these drugs.
With some nonsteroidal anti-inflammatory drugs, there are potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ocularly applied nonsteroidal anti-inflammatory drugs may cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery.<br><br>

<strong> Pregnancy & lactation:</strong> There are no adequate and well-controlled studies in pregnant women. Ketorolac tromethamine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised when it is administered to a nursing woman.<br><br>

<strong>Dosage & admin:</strong> Adult- 1 drop 4 times a day or as advised by the physician. Children- not recommended as safety and efficacy in pediatric patients have not been established. Drug inter: Methotrexate, diuretics. lithium, warfarin, digoxin and other NSAIDs.
   </p>
        </div><!-- collapsible -->
  
        <div data-role="collapsible"> <!-- collapsible -->
            <h3>EMODOL Eye Drop Jayson</h3>
            <p>Ketorolac tromethamine 0.5% (5mg/ml) sterile isotonic aqueous solution for ophthalmic use: eye drop.
        5ml drop: 60.68 IP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ETORAC Eye Drop Incepta</h3>
            <p>Ketorolac tromethamine 0.5% (5mg/ml) sterile isotonic aqueous solution for ophthalmic use: eye drop.
        5ml drop: 60.68 IP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>KEROLAC Eye Drop Gaco</h3>
            <p>Ketorolac tromethamine 0.5% (5mg/ml) sterile isotonic aqueous solution for ophthalmic use: eye drop
        5ml drop: 60.00 MR</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>LOPADOL Eye Drop Popular</h3>
            <p>Ketorolac tromethamine 0.5% (5mg/ml) sterile isotonic aqueous solution for ophthalmic use: eye drop.
        5ml drop: 80.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>RECULAR Eye Drop Reman</h3>
            <p>Ketorolac tromethamine 0.5% (5mg/ml) sterile isotonic aqueous solution for ophthalmic use: eye drop.
        5ml drop: 58.00 MRP</p>   
        </div><!-- collapsible -->

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->


<div data-role="page" id="KETOTIFEN" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> KETOTIFEN   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3>KETOTIFEN: Eye drop  </h3>
          <p>  Ketotifen fumarate BP 0.025% eye drops.<br><br>

           <strong>Mode of action:</strong> Ketotifen fumarate is a non- bronchodilator antiasthmatic drug with marked anti-anaphylactic property. In addition, ketotifen exerts a powerful and sustained H1 receptor blocking activity which can be clearly dissociated from its anti-anaphylactic property.<br><br>

<strong>Ind:</strong> Ketotifen is indicated for the treatment of allergic conjunctivitis.<br><br>

<strong>C/I:</strong> Ketotifen is contraindicated in patients with hypersensitivity to any of its ingredients.<br><br>

<strong>S/E:</strong> Drowsiness and in isolated cases dry mouth and slight dizziess may occur at the beginning of the treatment, but usually disappear spontaneously after a few days.<br><br>

<strong>Precautions:</strong> As with all ophthalmic preparations containing benzalkonium chloride, patients are advised not to instill ketotifen fumarate ophthalmic solution while wearing soft (hydrophilic) contact lenses. Wearers of soft contact lenses should be instructed to remove lenses prior to installation of drops and to wait at least ten minutes after instilling ketotifen before they insert their contact lenses.Do not use longer than one month after opening.<br><br>

<strong> Pregnancy & lactation:</strong> Ketotifen should not be used during pregnancy, except if the benefit justifies the potential risk to the fetus.<br><br>

<strong>Dosage & admin:</strong> Adults and children over 3 years of age: The recommended dose is one drop in the affected eye(s) 8 to 12 hourly or as directed by the physician. If dose misses, apply as soon as possible; not apply if almost time for the next dose.
Children below 3 years of age: Not recommended.  </p>
        </div><!-- collapsible -->
        
        <div data-role="collapsible"> <!-- collapsible -->
            <h3>FENAT Eye Drop Drug Inter</h3>
            <p>Ketotifen fumarate BP 0.025%: eye drop
        5ml drop: 65.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>KETOMAR Eye Drop Incepta</h3>
            <p>Ketotifen fumarate BP 0.03%: eye drop
        5ml drop: 90.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>PROSMA Eye Drop ACI</h3>
            <p>Ketotifen fumarate BP 0.025%: eye drop
        5ml drop: 80.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> STAFEN Eye Drop Aristopharma  </h3>
          <p>  Ketotifen fumarate BP 0.03%: eye drop 5ml drop: 95.00 MRP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ZADIT Eye Drop Popular</h3>
            <p>Ketotifen fumarate BP 0.025%: eye drop
        5ml drop: 95.00 MRP</p>   
        </div><!-- collapsible -->
      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->


<div data-role="page" id="LODOXAMIDE" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  LODOXAMIDE  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3> ALOMIDE Eye Drop Alcon/Globex </h3>
          <p> Lodoxamide tromethamine 0.17% equivalent to 0.1% lodoxamide + benzalkonium chloride 0.007% as preservative: Eye drop.
<br><br>

<strong>Mode of action:</strong> Lodoxamide tromethamine has antiallergic properties. It stabilizes mast cells and prevent the antigen specific induced release of histamine. Lodoxamide prevents the release of other mast cell inflammatory, mediators such as the slow reacting substances of anaphylaxis (or SRS-A). It inhibits histamine release by
preventing the movement of calcium into the mast cell after stimulation.<br><br>

<strong>Ind:</strong> Allergic/atopic conjunctivitis, vernal conjuctivitis and giant papillary conjuctivitis.<br><br>

 <strong>C/I:</strong> Hypersensitivity to lodoxamide or any component of the preparation.<br><br>

<strong>S/E:</strong> Mild and transient discomfort upon instillation expressed as burning, stinging, itching or tearing.<br><br>

Warnings & <strong>Precautions:</strong> As with all ophthalmic preparations containing benzalkonium chloride, users of soft (hydrophilic) contact lenses should refrain from wearing lenses while under treatment with lodoxamide. The recommended frequency of administrations should not be exceeded.<br><br>

<strong> Pregnancy & lactation:</strong> There is no study of lodoxamide use during pregnancy or concerning excretion in human milk.<br><br>

<strong>Dosage & admin:</strong> Adult & older children- 1 or 2 drops in each eye 4 times a day at regularintervals. Once symptomatic improvement has been established, therapy should be continued for as long as needed to sustain improvement.If required, corticosteroids may be used concomitantly with lodoxamide.Clinical studies on use in children below the age of four years have not been performed. Overdose: In the event of topical overdose, flush from the eye with running water.<br><br>

Storage: Store at room temperature and use within one month after opening the drop.
5ml drop: 295.28 MRP   </p>
        </div><!-- collapsible -->
  

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->


<div data-role="page" id="OLOPATADINE" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> OLOPATADINE   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3> OLOPATADINE: Eye Drop  </h3>
          <p>  Olopatadine hydrochloride INN 1mg/ml (0.1%): Eye drop<br><br>

<strong>Mode of action:</strong> Olopatadine inhibits release of histamine from the mast cell and a relatively selective histamine H1-antagonist. It inhibits the in vivo and in vitro type 1 immediate hypersensitivity reaction including inhibition of histamine induced effects on human conjunctival epithelial cells.<br><BR>

<strong>Ind:</strong> Olopatadine 0.1% eye drop is indicated for the treatment of the signs and symptoms of allergic conjunctivitis.<BR><BR>

<strong>C/I:</strong> Olopatadine preparation is contraindicated in persons with known hypersensitivity to olopatadine hydrochloride.<BR><BR>

<strong>S/E:</strong> Headaches have been reported in 7% cases. Other side effects are experienced in less than 5% of patients, such as- asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, ypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis and taste change.<br><br>

<strong>Precautions:</strong> Olopatadine ophthalmic solution should not be used to treat contact lens related irritation. Patients who wear soft contact lenses should be instructed to wait at least ten minutes after instilling olopatadine eye drop before they insert their contact lenses.<br><br>

<strong> Pregnancy & lactation:</strong> There are no adequate and well controlled studies in pregnant women. So, this drug should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the fetus. Caution should be exercised when olopatadine ophthalmic solution is administered to a nursing mother.<br>
<strong>Dosage & admin:</strong> One drop in each affected eye two times per day at an interval of 6 to 8 hours.  </p>
        </div><!-- collapsible -->
        
        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ALACOT Eye Drop Square</h3>
            <p>Olopatadine hydrochloride INN 1mg/ml (0.1%): Eye drop
        5ml drop: 70.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>OLODIN Eye Drop Reman</h3>
            <p>Olopatadine hydrochloride INN 1mg/ml (0.1%): Eye drop
        5ml drop: 80.00 IP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>OLPADIN Eye Drop Aristopharma</h3>
            <p>Olopatadine hydrochloride INN 1mg/ml (0.1%): Eye drop
        5ml drop: 100.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>PATALON Eye Drop Ibn Sina</h3>
            <p>Olopatadine hydrochloride INN 1mg/ml (0.1%): Eye drop
        5ml drop: 80.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>PATANOL Eye Drop Alcon/Globex</h3>
            <p>Olopatadine hydrochloride INN 1mg/ml (0.1%)
        5ml drop: 515.20 MRP</p>   
        </div><!-- collapsible -->
      </div><!-- collapsible-set -->

    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->


<div data-role="page" id="PEMIROLAST" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> PEMIROLAST   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3>MIROLAST Eye drop Incepta  </h3>
          <p>  Pemirolast potassium INN 0.1% (i.e 1mg/ml): Eye drop.<br>
<strong>Mode of action:</strong> Pemirolast potassium is a mast cell stabilizer that inhibits the invivo type-1 immediate hypersensitivity reaction. The drug has been observed to block antigen-stimulated calcium ion influx into mast cells. Invitro and invivo studies have demonstrated that pemirolast inhibits the antigen-induced release of inflammatory mediators (e.g histamine,
leukotriene C4, D4, E4) from human mast cells. Pemirolast also inhibits the chemotaxis of eosinophils into ocular tissue and prevents inflammatory mediator release from human eosinophils.<BR><BR>

<strong>Ind:</strong> Pemirolast eye drop is indicated for the prevention of itching of the eye due to allergic conjunctivitis.<BR><BR>

<strong>C/I:</strong> Known hypersensitivity to any of the
ingredients of the product.<BR><BR>

<strong>S/E:</strong> Burning of eye, dry eye, ocular discomfort, non ocular allergy, sinusitis, headache and sneezing or nasal congestion.<BR><BR>

<strong>Precautions:</strong> Patients should be advised not to wear contact lens if their eye(s) are red.Pemirolast should not be used to treat contact lens related irritation. Patients should wait 10 minutes after applying pemirolast before they insert contact lenses.<BR><BR>

Pregnancy & lactation: There are no adequate and well-controlled studies in pregnant women. Pemirolast eye drop should be used during pregnancy only if the benefit outweighs the risk. It is not known whether pemirolast is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when pemirolast eye drop is administered to a nursing woman.<BR><BR>

<strong>Dosage & admin:</strong> 1 to 2 drops in each affected eye 4 times daily.<BR><BR>

Pediatric use: Safety and effectiveness in pediatric patients below the age of 3 years have not been established.<BR><BR>

Drug inter: No specific information is available. 10ml drop: 75.00 MRP  </p>
        </div><!-- collapsible -->
  

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->


<div data-role="page" id="SODIUM CROMOGLYCATE" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  SODIUM CROMOGLYCATE  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

       <div data-role="collapsible"> <!-- collapsible -->
          <h3> SODIUM CROMOGLYCATE: Eye Drop  </h3>
          <p>  Sodium cromoglycate 2%: eye drop.
<strong>Ind:</strong> Allergic conjuctivitis; a mast cell stabiliser. <br><br>

<strong>C/I:</strong> Soft contact lenses.<br><br>

<strong>S/E:</strong> Transient stinging.<br><br>

<strong>Dosage & admin:</strong> Adult & child: 1 or 2 drops in each eye, 4 times daily.  </p>
        </div><!-- collapsible -->
        
        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ARISTOCROM Eye Drop Aristovision</h3>
            <p>Sodium cromoglycate 2%: eye drop.
        10ml drop: 60.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ICROM Eye Drop ACI</h3>
            <p>Sodium cromoglycate 2%: eye drop.
        10ml drop: 65.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ITCHIN Eye Drop Gaco</h3>
            <p>Sodium cromoglycate 2%: eye drop.
        10ml drop: 60.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>ITCHIN DS Eye Drop Gaco</h3>
            <p>Sodium cromoglycate 4%: eye drop. 10ml drop: 75.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>MASTGUARD Eye Drop Incepta</h3>
            <p>Sodium cromoglycate 2%: eye drop. 10ml drop: 60.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>NACROMIN Eye Drop Square</h3>
            <p>Sodium cromoglycate 2%: eye drop. 10ml drop: 61.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>NASOCHROM Eye Drop Drug Inter</h3>
            <p>Sodium cromoglycate 2%: eye drop. 10ml drop: 60.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>OPSOCROM Eye Drop Opso Saline</h3>
            <p>Sodium cromoglycate 2%: eye drop. 10ml pack: 55.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>OPTACROM Eye Drop Reman</h3>
            <p>Sodium cromoglycate 2%: eye drop. 10ml pack: 50.57 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>OPTIPAN Eye Drop Jayson</h3>
            <p>Sodium cromoglycate 2%: eye drop. 10ml pack: 50.57 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>SODICROM Eye Drop Popular</h3>
            <p>Sodium cromoglycate 2%: eye drop. 10ml pack: 50.00 MRP</p>   
        </div><!-- collapsible -->

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

	
</body> 
</html> 
